228 related articles for article (PubMed ID: 23981392)
1. Arbidol inhibits viral entry by interfering with clathrin-dependent trafficking.
Blaising J; Lévy PL; Polyak SJ; Stanifer M; Boulant S; Pécheur EI
Antiviral Res; 2013 Oct; 100(1):215-9. PubMed ID: 23981392
[TBL] [Abstract][Full Text] [Related]
2. Silibinin inhibits hepatitis C virus entry into hepatocytes by hindering clathrin-dependent trafficking.
Blaising J; Lévy PL; Gondeau C; Phelip C; Varbanov M; Teissier E; Ruggiero F; Polyak SJ; Oberlies NH; Ivanovic T; Boulant S; Pécheur EI
Cell Microbiol; 2013 Nov; 15(11):1866-82. PubMed ID: 23701235
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus entry depends on clathrin-mediated endocytosis.
Blanchard E; Belouzard S; Goueslain L; Wakita T; Dubuisson J; Wychowski C; Rouillé Y
J Virol; 2006 Jul; 80(14):6964-72. PubMed ID: 16809302
[TBL] [Abstract][Full Text] [Related]
4. A Novel Class of Small Molecule Compounds that Inhibit Hepatitis C Virus Infection by Targeting the Prohibitin-CRaf Pathway.
Liu S; Wang W; Brown LE; Qiu C; Lajkiewicz N; Zhao T; Zhou J; Porco JA; Wang TT
EBioMedicine; 2015 Nov; 2(11):1600-6. PubMed ID: 26870784
[TBL] [Abstract][Full Text] [Related]
5. Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection.
Boriskin YS; Pécheur EI; Polyak SJ
Virol J; 2006 Jul; 3():56. PubMed ID: 16854226
[TBL] [Abstract][Full Text] [Related]
6. The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses.
Pécheur EI; Borisevich V; Halfmann P; Morrey JD; Smee DF; Prichard M; Mire CE; Kawaoka Y; Geisbert TW; Polyak SJ
J Virol; 2016 Jan; 90(6):3086-92. PubMed ID: 26739045
[TBL] [Abstract][Full Text] [Related]
7. Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol.
Pécheur EI; Lavillette D; Alcaras F; Molle J; Boriskin YS; Roberts M; Cosset FL; Polyak SJ
Biochemistry; 2007 May; 46(20):6050-9. PubMed ID: 17455911
[TBL] [Abstract][Full Text] [Related]
8. Identification and Characterization of a Novel Broad-Spectrum Virus Entry Inhibitor.
Chou YY; Cuevas C; Carocci M; Stubbs SH; Ma M; Cureton DK; Chao L; Evesson F; He K; Yang PL; Whelan SP; Ross SR; Kirchhausen T; Gaudin R
J Virol; 2016 May; 90(9):4494-4510. PubMed ID: 26912630
[TBL] [Abstract][Full Text] [Related]
9. Clathrin mediates infectious hepatitis C virus particle egress.
Benedicto I; Gondar V; Molina-Jiménez F; García-Buey L; López-Cabrera M; Gastaminza P; Majano PL
J Virol; 2015 Apr; 89(8):4180-90. PubMed ID: 25631092
[TBL] [Abstract][Full Text] [Related]
10. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells.
Anggakusuma ; Colpitts CC; Schang LM; Rachmawati H; Frentzen A; Pfaender S; Behrendt P; Brown RJ; Bankwitz D; Steinmann J; Ott M; Meuleman P; Rice CM; Ploss A; Pietschmann T; Steinmann E
Gut; 2014 Jul; 63(7):1137-49. PubMed ID: 23903236
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol.
Teissier E; Zandomeneghi G; Loquet A; Lavillette D; Lavergne JP; Montserret R; Cosset FL; Böckmann A; Meier BH; Penin F; Pécheur EI
PLoS One; 2011 Jan; 6(1):e15874. PubMed ID: 21283579
[TBL] [Abstract][Full Text] [Related]
12. Aloperine inhibits hepatitis C virus entry into cells by disturbing internalisation from endocytosis to the membrane fusion process.
Lv XQ; Zou LL; Tan JL; Li H; Li JR; Liu NN; Dong B; Song DQ; Peng ZG
Eur J Pharmacol; 2020 Sep; 883():173323. PubMed ID: 32622669
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles.
Meertens L; Bertaux C; Dragic T
J Virol; 2006 Dec; 80(23):11571-8. PubMed ID: 17005647
[TBL] [Abstract][Full Text] [Related]
14. Arbidol: a broad-spectrum antiviral compound that blocks viral fusion.
Boriskin YS; Leneva IA; Pécheur EI; Polyak SJ
Curr Med Chem; 2008; 15(10):997-1005. PubMed ID: 18393857
[TBL] [Abstract][Full Text] [Related]
15. The length of vesicular stomatitis virus particles dictates a need for actin assembly during clathrin-dependent endocytosis.
Cureton DK; Massol RH; Whelan SP; Kirchhausen T
PLoS Pathog; 2010 Sep; 6(9):e1001127. PubMed ID: 20941355
[TBL] [Abstract][Full Text] [Related]
16. Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein.
Hung TC; Jassey A; Liu CH; Lin CJ; Lin CC; Wong SH; Wang JY; Yen MH; Lin LT
Phytomedicine; 2019 Feb; 53():62-69. PubMed ID: 30668413
[TBL] [Abstract][Full Text] [Related]
17. Host cell factors and functions involved in vesicular stomatitis virus entry.
Johannsdottir HK; Mancini R; Kartenbeck J; Amato L; Helenius A
J Virol; 2009 Jan; 83(1):440-53. PubMed ID: 18971266
[TBL] [Abstract][Full Text] [Related]
18. AP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets.
Neveu G; Ziv-Av A; Barouch-Bentov R; Berkerman E; Mulholland J; Einav S
J Virol; 2015 Apr; 89(8):4387-404. PubMed ID: 25653444
[TBL] [Abstract][Full Text] [Related]
19. Inhibitor analysis revealed that clathrin-mediated endocytosis is involed in cellular entry of type III grass carp reovirus.
Wang H; Liu W; Sun M; Chen D; Zeng L; Lu L; Xie J
Virol J; 2018 May; 15(1):92. PubMed ID: 29793525
[TBL] [Abstract][Full Text] [Related]
20. Membrane Fusion Assays for Studying Entry Hepatitis C Virus into Cells.
Denolly S; Cosset FL; Freitas N
Methods Mol Biol; 2019; 1911():219-234. PubMed ID: 30593629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
